IO BIOTECH INC (IOBT) Forecast, Price Target & Analyst Ratings

NASDAQ:IOBT • US4497781090

Current stock price

0.209 USD
+0.03 (+18.35%)
At close:
0.199 USD
-0.01 (-4.78%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IO BIOTECH INC (IOBT).

Forecast Snapshot

Consensus Price Target

Price Target
$1.66
+ 695.50% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 1, 2026
Period
Q4 / 2025
EPS Estimate
-$0.23
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
52.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.66
Upside
+ 695.50%
From current price of $0.21 to mean target of $1.66, Based on 10 analyst forecasts
Low
$0.39
Median
$0.51
High
$4.20

Price Target Revisions

1 Month
0.00%
3 Months
-69.21%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for IOBT. The average price target is 1.66 USD. This implies a price increase of 695.5% is expected in the next year compared to the current price of 0.209.
The average price target has been revised downward by 69.21% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

IOBT Current Analyst RatingIOBT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

IOBT Historical Analyst RatingsIOBT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
52.00%
IOBT was analyzed by 10 analysts. The buy percentage consensus is at 52. So analysts seem to be rather neutral about IOBT.
In the previous month the buy percentage consensus was at a similar level.
IOBT was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-26Piper SandlerDowngrade Overweight -> Neutral
2025-10-22Piper SandlerMaintains Overweight -> Overweight
2025-09-30TD CowenDowngrade Buy -> Hold
2025-09-29HC Wainwright & Co.Downgrade Buy -> Neutral
2025-08-12Morgan StanleyMaintains Overweight -> Overweight
2025-04-01HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-05HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-12HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-06HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-16Morgan StanleyMaintains Overweight -> Overweight
2024-09-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-03Morgan StanleyMaintains Overweight -> Overweight
2024-09-03Piper SandlerMaintains Overweight -> Overweight
2024-09-03HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-15HC Wainwright & Co.Maintains Buy -> Buy
2024-03-06HC Wainwright & Co.Reiterate Buy -> Buy
2023-09-28Piper SandlerInitiate Overweight
2023-09-13HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-15Morgan StanleyMaintains Overweight -> Overweight
2023-08-11HC Wainwright & Co.Reiterate Buy -> Buy
2023-03-15HC Wainwright & Co.Reiterate Buy
2023-01-24Morgan StanleyMaintains Overweight
2022-11-21HC Wainwright & Co.Initiate Buy
2021-11-30Cowen & Co.Initiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 1, 2026
Period
Q4 / 2025
EPS Estimate
-$0.23
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
52.19%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
47.02%

Next Earnings Summary

IOBT is expected to report earnings on 5/1/2026. The consensus EPS estimate for the next earnings is -0.23 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
IOBT revenue by date.IOBT revenue by date.
N/AN/AN/AN/A
768.68%		N/A
-66.47%		N/A
11.99%		N/A
57.14%		N/A
40.69%		N/A
30.77%		N/A
24.71%
EBITDA
YoY % growth
IOBT ebitda by date.IOBT ebitda by date.
N/AN/AN/A-71.32M
-33.45%		-91.228M
-27.91%		N/A
-3.13%		N/A
19.58%		N/A
9.19%		N/A
46.05%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
IOBT ebit by date.IOBT ebit by date.
-9.91M-10.15M
-2.42%		-41.23M
-306.21%		-71.42M
-73.22%		-91.443M
-28.04%		N/A
-5.50%		N/A
16.10%		N/A
28.69%		N/A
26.12%		N/A
-96.29%		N/A
78.02%		N/A
37.97%		N/A
68.37%		N/A
226.03%		N/A
201.76%
Operating Margin
IOBT operating margin by date.IOBT operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
IOBT eps by date.IOBT eps by date.
N/AN/AN/A-2.50
46.25%		-2.16
13.60%		-1.45
32.87%		N/A
12.42%		N/A
70.68%		N/A
-7.53%		N/A
56.69%		N/A
70.59%		N/A
-20.00%		N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.23
52.19%		-0.10
70.00%		-0.11
67.94%		-0.12
5.85%		-0.12
46.67%
Revenue
Q2Q % growth		12.475M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-19.462M
27.77%		-2.04M
90.97%		-19.788M
14.60%		-21.42M
-10.67%		-23.358M
-20.02%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

IOBT Yearly Revenue VS EstimatesIOBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 2033 10M 20M 30M 40M 50M
IOBT Yearly EPS VS EstimatesIOBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 -1 -2 -3 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

IO BIOTECH INC / IOBT Forecast FAQ

What is the price target for IOBT stock?

10 analysts have analysed IOBT and the average price target is 1.66 USD. This implies a price increase of 695.5% is expected in the next year compared to the current price of 0.209.

Can you provide the upcoming earnings date for IO BIOTECH INC?

IO BIOTECH INC (IOBT) will report earnings on 2026-05-01.

What are the consensus estimates for IOBT stock next earnings?

The consensus EPS estimate for the next earnings of IO BIOTECH INC (IOBT) is -0.23 USD and the consensus revenue estimate is 0 USD.

Can you provide the analyst count for IO BIOTECH INC stock?

The number of analysts covering IO BIOTECH INC (IOBT) is 10.